Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tenet Healthcare Corporation filings document the regulatory record of a healthcare services company with hospital operations, an ambulatory surgery platform and Conifer revenue cycle management services. Its 8-K reports disclose operating results, financial outlook updates, Regulation FD information, material agreements involving Conifer, and debt financing matters tied to senior secured first lien notes and senior notes.
Tenet's proxy and current reports also cover board composition, shareholder voting matters, executive compensation, officer transition agreements, controller and principal accounting officer appointments, equity-award terms, common stock, senior-note securities and related governance disclosures. These filings connect THC's capital structure and management oversight to its Ambulatory, Hospital and Conifer business activities.
Tenet Healthcare director Christopher S. Lynch received a grant of 1,188 restricted stock units tied to common stock. These 2026 May Restricted Stock Units were awarded at no exercise price and are structured as equity-based compensation.
The units vest on the first anniversary of the grant date, 27 May 2027, meaning Lynch must remain eligible through that date to receive the shares or cash. Each unit is the economic equivalent of one share of Tenet’s common stock, and Lynch may elect to receive up to 37% of the vested units in cash instead of shares.
KERREY J ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare Corp director J. Robert Kerrey received a new equity award as part of his compensation. He was granted 1,464 restricted stock units linked to the company’s common stock, with no cash paid by him for the grant.
The units are granted under Tenet’s Stock Incentive Plan and each unit represents the economic equivalent of one common share. These restricted stock units vest on the first anniversary of the grant date, and Kerrey may elect to receive up to 37% of the vested units in cash instead of shares. Following this award, his reported derivative holdings from this grant total 1,464 units.
Fitzgerald Meghan reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Meghan Fitzgerald received a grant of 1,188 restricted stock units (RSUs). These 2026 May RSUs were awarded at a stated price of $0.00 per unit as part of the company’s Stock Incentive Plan and are economically equivalent to shares of common stock.
The RSUs vest on the first anniversary of the grant date, aligning compensation with future service. Following this award, Fitzgerald holds 1,188 RSUs directly. She may elect to receive up to 37% of the vested RSUs in cash instead of common shares, making this a routine compensation-related equity grant rather than an open-market trade.
Fidelity Brokerage Services LLC submitted a Form 144 notice relating to Common stock of THC. The filing lists proposed sales tied to restricted stock vesting: 1,036 shares vested on 05/22/2026 and 4,602 shares vested on 05/26/2026.
The notice identifies the transactions as Restricted Stock Vesting and labels the shares as Compensation. The filing names Fidelity Brokerage Services LLC as the selling broker and references NYSE trading. Timing and cash‑flow treatment for any actual market sales are not detailed in the excerpt.
Tenet Healthcare director James L. Bierman exercised 1,333 restricted stock units into common stock. On this transaction date, 1,333 units, each economically equivalent to one share of Tenet Healthcare common stock, converted into 1,333 shares at a stated price of $0.00 per share.
Following the exercise, Bierman directly holds 36,604 shares of Tenet Healthcare common stock. The derivative award labeled as 2025 May Restricted Stock Units now shows zero remaining units, indicating this specific RSU grant has been fully settled into shares.
Tenet Healthcare director Christopher S. Lynch reported a routine equity compensation event. On May 22, 2026, he exercised 1,333 2025 May Restricted Stock Units, each equivalent to one share of Tenet Healthcare common stock, receiving 1,333 shares of Common Stock at a stated price of $0.00 per share.
Following the transaction, Lynch directly held 13,405 shares of Tenet Healthcare common stock. The derivative position in the 2025 May Restricted Stock Units was reduced to zero. A footnote states that his total reported holdings reflect a decrease of 278 shares from previously filed Forms 4 to correct an error.
Tenet Healthcare Corp director Nadja West reported routine equity compensation activity. On May 22, 2026, West exercised 1,333 restricted stock units that were economically equivalent to common shares, receiving Tenet common stock at a conversion price of $0.00 per share.
In connection with this settlement, 37% of the restricted stock units were settled for cash and 63% were settled in shares of Tenet common stock. West also disposed of 493 common shares back to the issuer at $173.78 per share. After these transactions, West directly owned 27,805 shares of Tenet common stock.
Tenet Healthcare director Tammy Romo reported routine equity compensation activity involving restricted stock units. On May 22, 2026, Romo exercised 1,333 restricted stock units, each equivalent to one share of common stock, and converted them into Tenet common shares.
On the same date, Romo returned 493 common shares to Tenet at $173.78 per share in a disposition to the issuer. After these transactions, Romo directly holds 36,199 common shares. A footnote states that 37% of the restricted stock units were settled for cash and 63% were settled in Tenet common stock.
Tenet Healthcare director Richard W. Fisher reported routine equity compensation activity. On May 22, 2026, he exercised 1,333 restricted stock units into common stock, then disposed of 493 shares back to the issuer at $173.78 per share. A footnote states that 37% of his restricted stock units were settled for cash and 63% for Tenet common shares. Following these transactions, he directly holds 9,632 shares of Tenet Healthcare common stock.